ABRDN WORLD HEALTHCARE FUND (THW) Fundamental Analysis & Valuation

NYSE:THW • US87911L1089

Current stock price

12.58 USD
-0.17 (-1.33%)
At close:
12.59 USD
+0.01 (+0.08%)
After Hours:

This THW fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. THW Profitability Analysis

1.1 Basic Checks

  • In the past year THW was profitable.
  • THW had a positive operating cash flow in the past year.
  • Of the past 5 years THW 4 years were profitable.
  • THW had a positive operating cash flow in 4 of the past 5 years.
THW Yearly Net Income VS EBIT VS OCF VS FCFTHW Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M

1.2 Ratios

Industry RankSector Rank
ROA 8.79%
ROE 10.92%
ROIC N/A
ROA(3y)10.13%
ROA(5y)6.3%
ROE(3y)12.69%
ROE(5y)7.86%
ROIC(3y)N/A
ROIC(5y)N/A
THW Yearly ROA, ROE, ROICTHW Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10

1.3 Margins

  • THW's Profit Margin has been stable in the last couple of years.
  • The Operating Margin and Gross Margin are not available for THW so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 507.25%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5Y-0.1%
GM growth 3YN/A
GM growth 5YN/A
THW Yearly Profit, Operating, Gross MarginsTHW Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200 -200 400 -400 600

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. THW Health Analysis

2.1 Basic Checks

  • The number of shares outstanding for THW has been increased compared to 1 year ago.
  • The number of shares outstanding for THW has been increased compared to 5 years ago.
  • The debt/assets ratio for THW has been reduced compared to a year ago.
THW Yearly Shares OutstandingTHW Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 0 0 0 0
THW Yearly Total Debt VS Total AssetsTHW Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

2.2 Solvency

  • THW has an Altman-Z score of 2.61. This is not the best score and indicates that THW is in the grey zone with still only limited risk for bankruptcy at the moment.
  • The Debt to FCF ratio of THW is 3.53, which is a good value as it means it would take THW, 3.53 years of fcf income to pay off all of its debts.
  • THW has a Debt/Equity ratio of 0.23. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF 3.53
Altman-Z 2.61
ROIC/WACCN/A
WACCN/A
THW Yearly LT Debt VS Equity VS FCFTHW Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M

2.3 Liquidity

  • THW has a Current Ratio of 0.75. This is a bad value and indicates that THW is not financially healthy enough and could expect problems in meeting its short term obligations.
  • THW has a Quick Ratio of 0.75. This is a bad value and indicates that THW is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.75
Quick Ratio 0.75
THW Yearly Current Assets VS Current LiabilitesTHW Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. THW Growth Analysis

3.1 Past

  • THW shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -44.44%.
  • Measured over the past years, THW shows a decrease in Earnings Per Share. The EPS has been decreasing by -7.47% on average per year.
  • Looking at the last year, THW shows a very negative growth in Revenue. The Revenue has decreased by -12.87% in the last year.
  • THW shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -1.92% yearly.
EPS 1Y (TTM)-44.44%
EPS 3YN/A
EPS 5Y-7.47%
EPS Q2Q%134.04%
Revenue 1Y (TTM)-12.87%
Revenue growth 3Y-3.15%
Revenue growth 5Y-1.92%
Sales Q2Q%-24.63%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
THW Yearly Revenue VS EstimatesTHW Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M 10M

More info and screens

Find the best growth stocksShow best growing peers

1

4. THW Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 9.32, the valuation of THW can be described as very reasonable.
  • When comparing the Price/Earnings ratio of THW to the average of the S&P500 Index (26.64), we can say THW is valued rather cheaply.
Industry RankSector Rank
PE 9.32
Fwd PE N/A
THW Price Earnings VS Forward Price EarningsTHW Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 14.93
EV/EBITDA N/A
THW Per share dataTHW EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. THW Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 10.20%, THW is a good candidate for dividend investing.
  • THW's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 10.2%

5.2 History

  • The dividend of THW decreases each year by -0.57%.
  • THW has been paying a dividend for at least 10 years, so it has a reliable track record.
  • THW has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)-0.57%
Div Incr Years0
Div Non Decr Years10
THW Yearly Dividends per shareTHW Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1

5.3 Sustainability

  • THW pays out 92.86% of its income as dividend. This is not a sustainable payout ratio.
  • The Dividend Rate of THW has been decling, while earnings will also be declining. This means the current dividend is most likely not sustainable.
DP92.86%
EPS Next 2YN/A
EPS Next 3YN/A
THW Yearly Income VS Free CF VS DividendTHW Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M
THW Dividend Payout.THW Dividend Payout, showing the Payout Ratio.THW Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

THW Fundamentals: All Metrics, Ratios and Statistics

ABRDN WORLD HEALTHCARE FUND

NYSE:THW (5/1/2026, 8:04:00 PM)

After market: 12.59 +0.01 (+0.08%)

12.58

-0.17 (-1.33%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Industry StrengthN/A
Industry GrowthN/A
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners16.24%
Inst Owner Change1.13%
Ins Owners0.01%
Ins Owner Change0%
Market Cap507.48M
Revenue(TTM)11.04M
Net Income(TTM)56.00M
Analysts0
Price TargetN/A
Short Float %0.31%
Short Ratio1.09
Dividend
Industry RankSector Rank
Dividend Yield 10.2%
Yearly Dividend1.33
Dividend Growth(5Y)-0.57%
DP92.86%
Div Incr Years0
Div Non Decr Years10
Ex-Date04-22
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 9.32
Fwd PE N/A
P/S 45.97
P/FCF 14.93
P/OCF 14.93
P/B 0.99
P/tB 0.99
EV/EBITDA N/A
EPS(TTM)1.35
EY10.73%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.84
FCFY6.7%
OCF(TTM)0.84
OCFY6.7%
SpS0.27
BVpS12.72
TBVpS12.72
PEG (NY)N/A
PEG (5Y)N/A
Graham Number19.6539 (56.23%)
Profitability
Industry RankSector Rank
ROA 8.79%
ROE 10.92%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 507.25%
GM N/A
FCFM 307.97%
ROA(3y)10.13%
ROA(5y)6.3%
ROE(3y)12.69%
ROE(5y)7.86%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5Y-0.1%
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF 3.53
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 60.71%
Current Ratio 0.75
Quick Ratio 0.75
Altman-Z 2.61
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)78.26%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-44.44%
EPS 3YN/A
EPS 5Y-7.47%
EPS Q2Q%134.04%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-12.87%
Revenue growth 3Y-3.15%
Revenue growth 5Y-1.92%
Sales Q2Q%-24.63%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-4.35%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-32%
FCF growth 3Y-11.14%
FCF growth 5Y-2.29%
OCF growth 1Y-32%
OCF growth 3Y-11.14%
OCF growth 5Y-2.29%

ABRDN WORLD HEALTHCARE FUND / THW Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for ABRDN WORLD HEALTHCARE FUND?

ChartMill assigns a fundamental rating of 2 / 10 to THW.


What is the valuation status for THW stock?

ChartMill assigns a valuation rating of 1 / 10 to ABRDN WORLD HEALTHCARE FUND (THW). This can be considered as Overvalued.


Can you provide the profitability details for ABRDN WORLD HEALTHCARE FUND?

ABRDN WORLD HEALTHCARE FUND (THW) has a profitability rating of 2 / 10.


What is the valuation of ABRDN WORLD HEALTHCARE FUND based on its PE and PB ratios?

The Price/Earnings (PE) ratio for ABRDN WORLD HEALTHCARE FUND (THW) is 9.32 and the Price/Book (PB) ratio is 0.99.